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The publication of the complete genome sequence for Mycobacterium tuberculosis H37Rv in 1998 has had a
great impact on the research community. Nonetheless, it is suspected that genetic differences have arisen in
stocks of H37Rv that are maintained in different laboratories. In order to assess the consistency of the genome
sequences among H37Rv strains in use and the extent to which they have diverged from the original strain
sequenced, we carried out whole-genome sequencing on six strains of H37Rv from different laboratories.
Polymorphisms at 73 sites were observed, which were shared among the lab strains, though 72 of these were
also shared with H37Ra and are likely to be due to sequencing errors in the original H37Rv reference sequence.
An updated H37Rv genome sequence should be valuable to the tuberculosis research community as well as the
broader microbial research community. In addition, several polymorphisms unique to individual strains and
several shared polymorphisms were identified and shown to be consistent with the known provenance of these
strains. Aside from nucleotide substitutions and insertion/deletions, multiple IS6110 transposition events were
observed, supporting the theory that they play a significant role in plasticity of theM. tuberculosis genome. This
genome-wide catalog of genetic differences can help explain any phenotypic differences that might be found,
including a frameshift mutation in the mycocerosic acid synthase gene which causes two of the strains to be
deficient in biosynthesis of the surface glycolipid phthiocerol dimycocerosate (PDIM). The resequencing of
these six lab strains represents a fortuitous “in vitro evolution” experiment that demonstrates how the M.
tuberculosis genome continues to evolve even in a controlled environment.
Publication of the whole genome sequence of the H37Rv
strain of Mycobacterium tuberculosis by Stewart Cole and col-
leagues in 1998 provided a breakthrough in tuberculosis (TB)
research (8), leading to insights into the biology, metabolism,
and evolution of this infectious pathogen. Large protein fam-
ilies related to fatty acid and polyketide biosynthesis, regula-
tion (e.g., sigma factors and two-component sensor systems),
drug efflux pumps and transporters, and the PE_PGRS pro-
teins (a large duplicated family unique to the M. tuberculosis
group of mycobacteria) were identified. In addition, trans-
posons, prophage-like elements, and other repetitive and/or
mobile genetic elements were identified (18). This genomic
information has played an essential role in interpreting gene
expression studies, modeling persistence, and identifying es-
sential proteins as putative targets for drug discovery. How-
ever, to date the functions of only half of the genes (1,756/
4,066) have been determined or predicted, and the rest remain
annotated as “hypothetical proteins” (6).
The H37Rv strain was initially selected for sequencing be-
cause it is a widely used laboratory strain that has retained its
virulence. H37Rv was initially derived from a clinical isolate,
H37, obtained from a patient with pulmonary tuberculosis in
1905. H37Rv falls in the T clade (5) and single-nucleotide
polymorphism (SNP) cluster group SCG-6b (12). The viru-
lence of H37Rv can be demonstrated in a number of animal
models. For example, SCID mice infected with H37Rv typi-
cally have a mean time to death of 30 to 35 days, depending on
the dose and route of inoculation (13).
An avirulent strain, H37Ra, was also derived from H37 by
culturing on solid egg medium and selecting for resistance to
lysis (42). The strain was found not to cause disease in guinea
pigs (43) or in mice (27). It has a colony morphology (smooth)
different from that of H37Rv (rough) and several other phe-
notypic differences (14, 29). The H37Rv (ATCC 25618) and
H37Ra (ATCC 25177) strains are maintained at the Trudeau
Institute in New York (3), although unfortunately, the original
H37 clinical isolate has been lost. Strain ATCC 27294 (TMC
102) is also frequently used as a representative of H37Rv in
studies and treated equivalently in the literature. ATCC 25618
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and ATCC 27294 were both isolated from the same patient in
different years, and both are fully drug susceptible.
The complete genome of H37Ra has been sequenced by
Zheng et al. (48), who found 272 polymorphisms compared to
the genome sequence determined by Cole et al. (8) for H37Rv.
However, a subset of the polymorphic sites were found to
match CDC1551, and upon resequencing of 85 such sites in
H37Rv, 79 were determined to be errors in the H37Rv refer-
ence sequence. In addition, H37Ra has insertions of IS6110 at
two novel sites and a loss of one, compared to the 16 sites in
H37Rv. The 130 genuine H37Ra-specific polymorphisms
found were divided into those in coding regions, those in up-
stream regulatory regions, and those in noncoding, nonregu-
latory intergenic regions in order to assess potential relevance
to virulence. Polymorphisms in the promoter regions of sigC,
nrdH (glutaredoxin-like electron transporter), and pabB (para-
amino benzoate synthase), as well as nonsynonymous substitu-
tions in mazG (regulator of stringent response), phoP (two-
component sensor regulating biosynthesis of cell surface lipid
antigens), pks12 (polyketide synthase involved in biosynthesis
of mycoketides), and nrp (nonribosomal peptide synthetase
potentially involved in phthiocerol dimycocerosate [PDIM]
biosynthesis), were highlighted as possible causes of the loss of
virulence. H37Ra does not synthesize a number of cell surface
antigens, including sulfolipid-1, trehalose mycolates, and
PDIM (7). The roles of mutations in phoP and sigM, both of
which regulate expression of genes involved in biosynthesis of
cell surface antigens, have been subsequently investigated,
though neither seems to be singularly responsible for the avirulence
of H37Ra (17, 35). Multiple mutations in PPE and PE_PGRS genes
are also observed in H37Ra, and there has been speculation
about the role of these genes in virulence (39). However, the
RvD2 region (an 8-kb region present in H37Ra but deleted in
H37Rv, including an IS6110 insertion element, mmpL14, and
several hypothetical genes) is known not to be responsible for
differences in virulence (25).
Because of its importance as a model strain used in labora-
tory studies, it is essential to determine how consistent differ-
ent stocks of H37Rv in different laboratories are with the
reference genome sequence and with each other. Different
stocks could accumulate independent polymorphisms over
time, and such inconsistencies could potentially make results of
studies obtained with H37Rv cultures from different labs dif-
ficult to compare, particularly if they affect virulence, drug
tolerance, metabolism, cell wall constitution, etc. Furthermore,
sequencing errors in the original genome sequence are possi-
ble. In order to evaluate differences among currently used
variants of H37Rv, we resequenced the complete genomes of
six extant H37Rv strains (two samples of ATCC 25618 and
four of ATCC 27294) using Illumina sequencing technology.
We compared differences among them and differences from
the reference sequences for H37Rv and H37Ra available from
GenBank. The results of this study identify a common set of 73
polymorphisms shared among all six sequenced strains relative
to the H37Rv reference strain. Most (72) of these are shared
with H37Ra and likely correspond to sequencing errors in the
original H37Rv genome sequence. However, there are several
sites where additional polymorphisms are shared among a sub-
set of strains, and several strains have a small number of
unique polymorphisms. Furthermore, examination of insertion
sites of the IS6110 transposable element reveals several
changes that have occurred among these strains. These results
illustrate the ongoing evolution of this strain and divergence
from the sequenced reference strain of H37Rv and highlight
the importance of understanding the genetic differences
unique to the stock used in each laboratory.
MATERIALS AND METHODS
DNA sequencing. Genomic DNA was extracted using the cetyltrimethylam-
monium bromide (CTAB)-lysozyme protocol described previously (26). The
DNA library was constructed using a genomic DNA sample preparation kit from
Illumina. The sample was first fragmented using a nebulization technique, and
then the double-stranded DNA fragments comprised of 3 or 5 overhangs were
converted into blunt ends, using T4 DNA polymerase and Klenow enzyme.
Klenow exo (lacking the 3-to-5 exonuclease) was used to add an A base to the
3 end of the blunt phosphorylated DNA fragments so that the fragments could
be ligated to the adaptors, which have a single T base overhang at their 3 end.
The ligated DNA was then size selected on a 2% agarose gel. DNA fragments of
about 300 bp were excised from the preparative portion of the gel. DNA was then
recovered using a Qiagen gel extraction kit and was PCR amplified to produce
the final DNA library. Five picomoles of DNA from each strain was loaded onto
a different lane of the sequencing chip (eight lanes total), and the clusters were
generated on the cluster generation station of the GAII using the Illumina
cluster generation kit. Bacteriophage X174 DNA was used as a control. In the
case of paired-end reads, distinct adaptors from Illumina were ligated to each
end with PCR primers that allowed reading of each end as separate runs. The
sequencing reaction was run for 36 cycles (tagging, imaging, and cleavage of one
terminal base at a time), and four images of each tile on the chip were taken in
different wavelengths for exciting each base-specific fluorophore. For paired-end
reads, data were collected as two sets of matched 36-bp reads. Image analysis and
base calling were done using the Illumina GA Pipeline software.
Comparative genome assembly. The 36-bp reads that were generated for each
strain were mapped against H37Rv as a reference sequence (accession on.
NC_000962, downloaded from NCBI) via ungapped alignments allowing up to
two mismatches. For reads that mapped to multiple locations, one was chosen at
random. For paired-end data, mapping locations of each read were restricted to
sites within 300 bp of mapping locations of its partner. The base calls were made
by a multiplying the base probabilities of the individual bases covering each site
(extracted from Q-values output by the Pipeline software, encoding uncertainty
about spot interpretation during image analysis) and taking the base with the
highest combined likelihood. Apparent differences (at sites where the consensus
base from overlapping reads differed from the expected base in the reference
sequence), along with sites where coverage was low (5) or observed bases
were heterogeneous (majority base  70%), were identified, and local contig
building was applied. Contigs were built by a best-first-search algorithm that
starts with a read matching100 bp upstream, contains a sequence of reads with
perfect overlaps of at least 25 bp, and ends in a read matching 100 bp down-
stream. Alignment of the consensus sequence of the contig to the corresponding
region in the reference genome revealed whether SNPs or insertions/deletions
(indels) were present. These polymorphisms were compiled for each strain and
used to modify the H37Rv sequence into edited genome sequences for each
strain. Finally, all the reads for each strain were remapped against the corre-
sponding intermediate sequence, and the base calls at each site were recalculated
as described above. Whole-genome alignments for comparative analyses were
generated using MUMMER v 3.20 (24).
RESULTS
Samples of six H37Rv strains obtained from separate labo-
ratories were sequenced using an Illumina GenomeAnalyzerII
(Table 1). All strains were sequenced with a read length of 36
bp, though two were sequenced in single-end mode and four in
paired-end mode (where reads are sequenced from both ends
of 250-bp fragments, providing additional localization con-
straints). The depth of coverage ranged between 29.4
(H37RvHA) and 151.3 (H37RvJO). The genomes were se-
quenced to 97.97% completion (defined as sites covered by
at least one read), with the remaining sites with zero depth of
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coverage largely confined to the highly GC-rich coding regions
of PE_PGRS genes, where sequencing is not as efficient. The
spoligotypes of the strains were determined by matching se-
quencing data (reads) to the oligonucleotide sequences of the
43 spacers in the direct-repeat (DR) region (20). While
H37RvLP, H37RvJO, and H37RvCO have spoligotype pat-
terns that match the general pattern for the H37Rv reference
sequence (octal representation, 777777477760771; missing
spacers 20 to 21 and 33 to 36), the other three strains
(H37RvAE, H37RvMA, and H37RvHA) are missing an addi-
tional spacer, number 26. The distinct spoligotypes suggest a
clustering of the strains into subgroups based on phylogenetic
relationships (see below).
There are 72 polymorphisms that are shared in common
among all six H37Rv variants plus H37Ra, in comparison to
the H37Rv reference sequence. These include 57 single-nucle-
otide polymorphisms (SNPs) and 15 insertions/deletions (in-
dels) 1 to 3 bp in length, although polymorphisms in PE_PGRS
genes were excluded (due to ambiguity caused by low cover-
age). Among the SNPs, there are 6 in noncoding regions, 21
synonymous mutations, and 30 nonsynonymous mutations.
Rv0197 and pstA1 show truncations (mutations to a stop codon
mid-open reading frame [ORF]), and pks3 and Rv1783 show
mutations in their stop codons to extend their ORFs. There are
eight indels in coding regions, causing frameshift mutations in
Rv0197, PPE7, Rv0907, Rv1046c, Rv1575, Rv2251, Rv3655c,
and sigM. Of the 15 mutations in noncoding regions, 6 are
within putative regulatory regions (100 bp upstream of cod-
ing regions). It should also be noted that there are two local
clusters of SNPs (12 within a 137-bp span in PPE9 and 14
within an 80-bp span in PPE47) that are not included in this
analysis.
There is only one site where there is a polymorphism shared
only among the five H37Rv variant strains but not the H37Rv
or H37Ra reference strains: A459399C in a noncoding region,
at 84 bp upstream of Rv0383c. This SNP appears to be
unique to the H37Rv lab strains as a group. H37Ra has a 55-bp
deletion in this region.
Many of these sites are consistent with errors discovered in
the H37Rv reference sequence upon resequencing by Zheng et
al. (48). Of 48 successfully resequenced sites with apparent
SNPs in the H37Ra genome that matched CDC1551 but not
H37Rv (excluding SNPs in PE_PGRS genes, PPE9, and
PPE47), they found only 3 sites with genuine differences, and
the rest turned out to be errors in the H37Rv sequence. Our
results agree exactly with the resequencing, in that all of the 45
errors appear as shared SNPs among our H37Rv lab strains
shown in Table 2, and the 3 genuine SNPs between H37Rv and
H37Ra were not found in the H37Rv lab strains (position
754186, G to A; position 1077312, G to A; and position
4100975, C to T [these remain unique to H37Ra]). Nine of the
15 indels in our study were also resequenced by Zheng et al.
(48), and all were confirmed as errors in the H37Rv sequence,
including the frameshift in amino acid (aa) 160 of sigM (short-
ening the ORF from 222 aa in H37Rv to 196 aa in H37Ra).
Polymorphisms unique to certain strains or shared among a
subset of strains were also identified, potentially representing
differences among the stock cultures (Table 3). None of the
differences were shared with H37Ra, which matched H37Rv at
all these sites. Six polymorphisms were shared among
H37RvAE, H37RvMA, H37RvHA, and H37RvCO, which are
ATCC 27294 specific. One of these is a CCG deletion in
ponA1 (a predicted penicillin-binding transpeptidase/transgly-
cosylase gene) corresponding to Pro630, which is an apparent
reduction in copy number of a CCGn tandem-repeat region
from six copies in H37Rv and H37Ra to five copies. Four
polymorphisms are shared by only H37RvAE, H37RvMA, and
H37RvHA, including three SNPs (in lprO [silent], Rv2604c,
and a noncoding region) and CAC in Rv2553c (a hypothet-
ical protein). The similarity of these strains is consistent with
the spoligotyping results, suggesting that these three strains
form a derived subgroup. Three unique mutations are ob-
served in H37RvAE (in Rv1063c [silent], fadD31, and ppsA).
The mutation H620N in fadD31, encoding an acyl coenzyme A
(acyl-CoA) ligase, is outside the boundaries of the AMP-bind-
ing domain (spanning residues 70 to 553 according to Pfam
[http://pfam.sanger.ac.uk]) and thus is unlikely to affect func-
tion. The mutation in ppsA is a nonsense mutation (W1294*).
ppsA encodes a multidomain polyketide synthase involved
in PDIM biosynthesis, specifically the polymerization of the
phthiocerol component. The mutation occurs near the C ter-
minus of the protein product (total length, 1,876 amino acids)
and would truncate the terminal acyl carrier protein (ACP)
domain and thus presumably abrogate the function of ppsA. It
is most likely that this mutation is a one-off mutation (specific
to the sample sequenced) that occurred between passaging and
is not propagated in the parental strain, as this strain is regu-
larly passaged in mice and retains virulence and PDIM pro-
duction (W. R. Jacobs, Jr., unpublished results). Supporting
this, we did not observe the ppsA W1294* mutation in several
isogenic mutants that we sequenced. Mutations in genes in-
volved in PDIM biosynthesis are frequently observed in strains
maintained in the laboratory without the selective pressure to
TABLE 1. H37Rv strains sequenced in this study
Strain ATCC no. Source Spoligotypea Sequencing Coverage()
Completion
(%)
H37RvAE 27294 William Jacobs (Albert Einstein College of Medicine) 777777475760771 Single end 63.3 99.98
H37RvMA 27294 Chris Sassetti (University of Massachusetts) 777777475760771 Paired end 62.3 99.22
H37RvCO 27294 Karen Dobos (Colorado State University) 777777477760771 Paired end 79.2 98.77
H37RvHA 27294 Sarah Fortune (Harvard University) 777777475760771 Single end 29.4 99.37
H37RvLP 25618 Tanya Parish (IDRI, Seattle, WA) 777777477760771 Paired end 151.3 99.00
H37RvJO 25618 Valerie Mizrahi (Johannesburg, South Africa) 777777477760771 Paired end 49.7 98.78
a Spoligotype inferred from matching sequence data (36-bp reads) to spacer oligonucleotides. For comparison, the spoligotype of the H37Rv reference strain is
777777477760771.
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TABLE 2. Shared polymorphisms among all five H37Rv lab strains and H37Ra, relative to H37Rva
Rv no. Gene Coordinateb Mutation Amino acidsubstitutionc Comment
Rv0012 14785 T3 C C233R
Rv0050 ponA1 55553 C3 T P631S
Rv0064 69989 G3 A G457D
Rv0082 90144 A3 G Q74R
Rv0083 91071 T3 C I224I
Rv0101 nrp 116000 T3 G V2000V
NC 131177 G 73 bp upstream of Rv0108c
Rv0197 234477 T3 G Y749* Reduces length by 14 aa
Rv0197 234497 GT
Rv0204c 242299 C3 G V306L
Rv0323c 390828 T3 C S142G
Rv0354c PPE7 424323 C
Rv0355c PPE8 426909 A3 C W2591G
Rv0382c pyrE 458282 A3 G Y33Y
Rv0425c ctpH 511518 T3 G I1268I
Rv0442c PPE10 532097 T3 C K40E
Rv0461 552085 A3 G Q20Q
Rv0473 563577 A3 G K5R
Rv0682 rpsL 781922 A3 G K121K
Rv0890c 990001 G3 C P866A
Rv0907 1010207 G
Rv0919 1025106 T3 C F141F
Rv0930 pstA1 1037911 C3 T R305* Reduces length by 4 aa
Rv1046c 1168718 T
Rv1121 zwf1 1244700 T3 C L332L
NC 1313338 A3 G 39 bp upstream of Rv1179c
NC 1313339 C 40 bp upstream of Rv1179c
Rv1180 pks3 1315191 A3 C *489Y Fuses ORF with pks4
Rv1181 pks4 1315884 G3 A A217A
Rv1185c fadD21 1327402 T3 C E37E
Rv1188 1331696 A3 C R226R
Rv1266c pknH 1414021 C3 T R607Q
Rv1297 rho 1453608 T3 C G135G
NC 1471659 C3 T
Rv1575 1780588 G In aa A220
Rv1677 dsbF 1901816 A3 G Q23Q
Rv1783 2020563 A3 T *463L Fuses ORF with Rv1784
Rv1808 PPE32 2050913 A3 G E331E
Rv1809 PPE33 2051746 T3 C A155A
Rv1815 2057774 A3 T I83F
NC 2167489 T3 C
Rv1925 fadD31 2177654 A3 C M190L
NC 2207592 C
Rv1979c 2221796 C3 T V457I
NC 2251999 A3 G 3 bp upstream from otsB1
Rv2037c 2282787 C3 T C312Y
Rv2048c pks12 2297976 G3 A S3004L
Rv2101 helZ 2361623 A3 C M462L
Rv2205c 2470149 T3 C E105E
NC 2505919 A3 G
NC 2523208 CCG
Rv2251 2525727 G In aa E55
NC 2718852 T3 G 44 bp upstream of nadD
Rv2450c rpfE 2751804 C3 T R126Q
Rv2495c pdhC 2809621 T3 C T107A
Rv2614A 2943411 T3 C L12L
Rv2627c 2954439 T3 C R104G
Rv2680 2996194 T3 A V30V
Rv2695 3012293 A3 G T126T
Rv2896c 3205978 A3 C S153A
Rv2932 ppsB 3254365 T3 C L1098L
Rv3011c gatA 3370177 T3 G M420L
Rv3144c PPE52 3510642 T3 C S226G
NC 3580637 T 1 bp upstream from lipV
NC 3590687 C
Rv3331 sugI 3718357 C3 T P423L
NC 3862474 A 84 bp upstream from rplM
Rv3479 3896340 T3 G L174R
Rv3655c 4095002 G
Rv3704c gshA 4147070 A3 G L373L
Rv3911 sigM 4400663 C In aa R160
Rv3919c gidB 4407904 G3 A S100F
a Amino acid translations for mutations in coding regions are given. Mutations in noncoding regions (NC) were checked to see if they were within 100 bp of the
translational start site of a nearby coding region, and if so, the gene and distance are indicated.
b Relative to the H37Rv reference sequence.
c *, stop codon.
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maintain virulence (11), reinforcing the value of regular pas-
saging in mice.
The two ATCC 25618 samples, H37RvLP and H37RvJO,
share five mutations, including a frameshift mutation GC in
mas (encoding mycocerosic acid synthase, which is also in-
volved in PDIM biosynthesis) in amino acid 829 out of 2,111.
This mutation is known to disrupt the function of mas, as
H37RvJO has been shown to be PDIM deficient (21). How-
ever, both H37RvLP and H37RvJO are fully virulent in mice
(21, 33). This would appear to contradict reports that PDIM
deficiency correlates with reduced virulence (10). One possible
explanation for this discrepancy could be a difference in ge-
netic backgrounds, e.g., a compensating mutation that allows
these strains to retain virulence despite loss of PDIM. There
are three mutations shared between H37RvLP and H37RvJO
(other than the frameshift in mas and a synonymous mutation
in Rv0573c): R9H in Rv0480c, P402S in Rv0538, and a 17-bp
deletion in Rv3785. Rv0480c encodes a putative nitrilase, but
the mutation occurs in the N terminus, which is on the surface
of the protein, not the active site, based on the crystal structure
of the yeast homolog (Protein Data Bank [PDB] accession no.
1F89). Rv3785 is a hypothetical protein of unknown function.
However, Rv0538 has previously been recognized as an immu-
nogenic protein (38). Rv0538 is a 548-amino acid membrane
protein of unknown function containing Pro/Thr repeats, and
hence it is also called proline-threonine repetitive protein
(PTRP). In a study aimed at identifying antigenic proteins for
potential diagnostic development, antibodies to Rv0538 were
TABLE 3. Polymorphic sites containing mutations unique to one lab strain or shared among a subset (excluding polymorphisms
in PPE and PE_PGRS proteins)
Mutation type and positiona
Mutation in strainb:
H37RvCO H37RvAE H37RvMA H37RvHA H37RvLP H37RvJO
Mutations shared by all H37Rv variants
but not found in H37Ra
459399/NCc A3 C A3 C A3 C A3 C A3 C A3 C
Mutations shared by cluster 1
Rv0050/ponA1 CCG CCG CCG CCG
Rv0543c A81A A81A A81A A81A
Rv0861c/ercc3 A410A A410A A410A A410A
Rv1520 Y200Y Y200Y Y200Y Y200Y
Rv1771 Q291R Q291R Q291R Q291R
Rv1907c V158A V158A V158A V158A
Mutations shared by cluster 2
Rv0179c/lprO L239L L239L L239L
986204/NC C3 A C3 A C3 A
Rv2553cd CAC(1) CAC(1) CAC(1)
Rv2604c D151E D151E D151E
Mutations unique to H37RvAE
Rv1063c R83R
Rv1925/fadD31 H620N
Rv2931/ppsA W1294*
Mutations shared by cluster 3
Rv0480c R9H R9H
Rv0538 P402S P402S
Rv0573c L275L L275L
Rv2940c/mase GC GC
Rv3785 17 bp 17 bp
Mutations unique to H37RvLP
Rv0282 Y275H
Rv0573c F252V
Rv1949c G236G
Rv2946c/pks1 D1463E
Rv3645 V393A
Mutations unique to H37RvJO
Rv0282 D138G
1108537/NCf A3 G
Rv2542 A348T
a NC, mutation is in a noncoding region.
b *, mutation to a stop codon.
c 84 bp upstream of Rv0383c; H37Ra has a 55 bp deletion here.
d In amino acid 53 out of 417 in Rv2553c (hypothetical protein).
e In amino acid 829 out of 2,111 in mas (mycocerosic acid synthase).
f 33 bp upstream of Rv0991c.
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found with high frequency in HIV-negative, TB-positive pa-
tients (38). Peptide epitope mapping identified four 20-amino-
acid regions that each bound antibodies in sera of 50% of
patients with active infections, and Pro402 is located directly in
the middle of the third region, PT40. Though the connection
between Rv0538 and virulence is still unresolved, this study
directly links the site of the P402S SNP in Rv0538 shared by
H37RvLP and H37RvJO to stimulation of the immune re-
sponse of the host and therefore could be part of the explana-
tion for how these strains retain their virulence despite the loss
of PDIM production.
Several of the mutations observed among these six H37Rv
strains (7 out of 20 in coding regions) are silent and thus
unlikely to cause phenotypic differences. However, the func-
tional relevance of the remaining mutations, many of which are
conservative (e.g., D151E in Rv2604c and V393A in Rv3645),
is unknown. The SNP in pks1 in H37RvLP probably does not
cause a phenotype, since it is part of a disrupted polyketide
synthase gene that produces phenolglycolipid (PGL) in other
strains of M. tuberculosis but which has been split into two
ORFs (pks15 and pks1) by a frameshift mutation in H37Rv and
thus is already nonfunctional (9). Of the three SNPs that occur
in noncoding regions, two are in putative regulatory regions
near the transcriptional start sites of operons. The closest one
is an A-to-G substitution 33 bp upstream of Rv0991c (encoding
a hypothetical protein). Of four indels observed, two are in
frame (3 bp in ponA1 and 3 bp in Rv2553c), and two cause
frameshifts (in mas [discussed above] and Rv3785, encoding
another hypothetical protein whose function is presumably
disrupted in H37RvLP and H37RvJO).
The polymorphisms shared among certain strains suggest
that they can be clustered by similarity. A phylogenetic tree
was constructed using maximum parsimony (dnapars in
PHYLIP 3.66) based on the polymorphic sites list in Table 3
(Fig. 1), augmented with genuine differences between H37Rv
and H37Ra not attributed to sequencing errors (48). As ex-
pected, this phylogeny suggests that H37RvLP and H37RvJO
diverged from H37RvCO, H37RvAE, H37RvMA, and
H37RvHA, forming two distinct clusters, consistent with their
typing as ATCC 25618 and ATCC 27294, respectively. There
are five ATCC 25618-specific polymorphisms and six ATCC
27294-specific polymorphisms distinguishing the highest-level
branches. Subsequently, H37RvAE, H37RvMA, and
H37RvHA diverged from H37RvCO as a subcluster. Several of
the strains subsequently accumulated a small number of inde-
pendent mutations (three in H37RvAE, five in H37RvLP, and
three in H37RvJO). The number of polymorphisms in each
strain is small compared to the number of differences between
the H37Rv and H37Ra (30 SNPs, excluding those in PE_PGRS
genes). Note that H37Rv is on a shallow branch because all of
the sequencing errors have been filtered out, leaving only one
site (position 459399, A to C) where it differs from all the other
strains.
In addition to the small number of substitutions and inser-
tions/deletions distinguishing these variant strains of H37Rv,
there are also several differences in insertion sites of the
IS6110 transposable element. All six strains have the same 16
copies of IS6110 as in the H37Rv reference strain, with three
exceptions. First, H37RvLP and H37RvJO have lost IS6110 12,
located at coordinate 3.55 Mb. Second, H37RvJO has a novel
insertion site at coordinate 3.49 Mb, disrupting Rv3128c, en-
coding a hypothetical protein of unknown function. This site
occurs in a 556-bp region called NTF-1, in which Beijing strains
of M. tuberculosis also have one or two unique IS6110 inser-
tions (23, 34). Third, H37RvCO contains a novel IS6110 inser-
tion site in plcD 617 bp upstream from the site in H37Rv. In
addition, H37RvAE, H37RvMA, and H37RvHA appear to
have only one copy in this region and lack the intervening
portion of plcD. This can be explained by a series of three
IS6110 insertion/loss events (Fig. 2). H37Ra shows an insertion
in the coding region of plcD, along with an additional one
downstream, creating an adjacent pair and spanning several
genes in between (including mmpL14). It was postulated that
the IS pair may have been ancestral and that the 8-kb region,
including the upstream IS element, was lost in H37Rv (25). It
appears that after this event, a new insertion of IS6110 oc-
curred even further upstream in plcD in a progenitor of four of
the six H37Rv lab strains, resulting in the pattern observed in
H37RvCO. Subsequently, this IS and the intervening portion
of plcD in H37RvAE, H37RvMA, and H37RvHA were de-
leted, probably through homologous recombination with the
IS6110 element downstream. Given the frequency of insertion
events in this region, it is likely that plcD represents a “hot
spot” for IS6110 insertion sites (37, 45). However, these inser-
tion/deletion events probably do not have any functional rele-
vance, since they are in a gene that is already disrupted.
DISCUSSION
The inferred phylogenetic relationships among the strains
based on SNP analysis (Fig. 2) are consistent with the known
FIG. 1. Maximum-parsimony tree of relationships among strains.
Branch lengths represent number of nucleotide differences (total tree
length 	 57).
FIG. 2. Proposed history of IS6110 insertion/deletion events in the
region of plcD. “hypo” indicates coding regions annotated as encoding
hypothetical proteins in the H37Ra genome.
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provenance of these six strains. H37RvCO was obtained from
the Trudeau Institute as ATCC 27294 (TMC 102) in 1969 for
the laboratory at Colorado State University. H37RvAE in W.
Jacob’s lab was obtained from the original ATCC 27294 stock
at the Trudeau Institute in the 1970s. Subsequently, strain
H37RvHA was obtained from Barry Bloom’s laboratory, which
had obtained it from the Albert Einstein stock, and was trans-
ferred to S. Fortune’s lab at Harvard in the late 1990s.
H37RvMA was derived from this stock for C. Sassetti’s group
at the University of Massachusetts Medical School in 2000.
Independently, H37RvLP (“London Pride”) was obtained by
T. Parish as ATCC 25618 from the National Institute of Med-
ical Research (NIMR) in London around 1994. This strain was
then maintained at the London School of Hygiene & Tropical
Medicine (LSHTM). H37RvJO was obtained from LSHTM in
1998. This history supports the main division between the clus-
ters of strains based on SNP analysis (H37RvAE, H37RvSF,
H37RvMA, and H37RvCO [three of which passed through the
Jacobs lab] versus H37RvLP and H37RvJO [which passed
through NIMR]). It can also be used to give an interpretation
of the IS6110 insertion/deletion events in the plcD region. It is
likely that the novel IS6110 insertion in plcD occurred early in
the Trudeau H37Rv stock before H37RvCO was sampled and
that it was subsequently lost by H37RvAE during maintenance
in the Jacobs lab and inherited by the other strains derived
from it (H37RvHA and H37RvMA). Three other shared SNPs
and an indel are associated with this lineage, though Jacobs’
stock has gone on to acquire several additional unique poly-
morphisms.
While H37Rv is widely regarded as a standard virulent ref-
erence strain for studies of tuberculosis, it has been recognized
that genetic differences among stocks from different labs are
possible. Furthermore, it has been suggested that there are
sequencing errors in the H37Rv reference genome sequence,
which can complicate the interpretation of polymorphisms ob-
served in isogenic mutants. Thus, we undertook the sequencing
of the complete genomes of six strains of H37Rv from distinct
laboratories. Indeed, the lab strains were found to have 73
common differences from the H37Rv reference strain. How-
ever, nearly all of these are shared with the avirulent strain
H37Ra, and upon resequencing of H37Rv by Zheng et al. (48),
they appear to be errors in the original H37Rv sequence.
Hence, apparent polymorphisms at these loci can be disre-
garded.
Nonetheless, there are several differences that were ob-
served among the six H37Rv lab strains. Several strains share
polymorphisms, dividing them into two distinct clusters with
five and six common polymorphisms each. This primarily re-
flects the difference between the two culture types, ATCC
25618 and ATCC 27294. Both are frequently used as H37Rv
reference strains in experimental studies and often are treated
interchangeably. However, they are not always phenotypically
identical (for example, ATCC 25618 has a slightly higher
pyrazinamide MIC than ATCC 27294 [40]), and to date it has
not been clear how they differ genetically. Our sequencing
results show that there are a combined 11 differences between
these two versions of H37Rv. In addition, several strains have
a small number of unique mutations (three to five) that were
acquired independently, making them distinct even within each
cluster. Further genetic variations observed include two inde-
pendent insertions and two deletions of IS6110 transposable
elements, as well as the loss of an additional spacer in the
direct-repeat (DR) region in one cluster of strains, leading to
a change in spoligotype. It has been argued that the transpo-
sition of IS6110 insertion elements plays a significant role in
the evolution of the M. tuberculosis genome (31), and this was
observed even on the small scale of this study. For comparison,
the rate of change among IS6110 insertions sites in vivo
(among clinical isolates) has been estimated at 2.87% per site
per year (36). The observed differences among the strains
sequenced clearly demonstrate that the stocks of H37Rv in
different laboratories are genetically distinct.
The general belief that M. tuberculosis, and H37Rv in par-
ticular, has a comparatively stable genome is due in part to the
low diversity observed among isolates worldwide (typically dif-
fering by 0.01% at the genetic level). However, this should
not be misinterpreted as evidence for a low mutation rate, as
the frequency of selection of mutants resistant to various drugs
falls in the range of 105 to 108, which is typical of other
prokaryotes (22). Instead, the low diversity has been attributed
to a population bottleneck estimated at occurring 15,000 to
20,000 years ago (41). M. tuberculosis continues to evolve, as
evidenced by independent outbreaks of drug resistance (47);
loss of deletion regions (44); and relocation of transposons,
changes in copy number of tandem repeats, and other genomic
characteristics often exploited for genotyping (30). Ongoing
evolution has also been observed in vitro via accumulation of
genetic differences during serial passaging of cultures (32).
Genetic variation as a result of culturing has been observed in
many other bacterial species as well (15), including Escherichia
coli (1, 19), Streptococcus (28), Campylobacter jejuni (16), and
Helicobacter pylori (46), often leading to phenotypic changes in
virulence. Some evolution is driven by selection largely for
mutations that accelerate growth in vitro. For example, loss of
PDIM synthesis, which is often associated with reduced viru-
lence, results in more rapid growth in laboratory media (11).
Moreover, changes in Mycobacterium bovis passaged over mul-
tiple generations resulted in the strain, M. bovis BCG, that is
no longer able to cause disease (2) and therefore was chosen as
a vaccine and, prior to the availability of methods for preserv-
ing strains, was further propagated. However, while some char-
acteristics are selected, many genetic changes likely occur due
to simple genetic drift. For example, while M. bovis BCG has
some changes that result in decreased virulence, the majority
of alterations have no known consequence (4).
Our whole-genome sequencing results show that differences
among H37Rv strains have also arisen over time. The differ-
ences are few (on the order of 5 to 10 polymorphisms per
strain, after errors in the original reference sequence are ruled
out) but potentially functionally relevant, such as nonsynony-
mous mutations in PDIM biosynthesis genes and possibly
other hypothetical proteins whose functions are currently un-
known. The variation we see among isolates passaged for a
limited amount of time in separate laboratories could repre-
sent a mixture of selected and random events that become
fixed with the genetic bottleneck associated with transfer of
clones among investigators. Thus, the notion of H37Rv as a
standard reference strain should be used with some caution, as
experimental results derived with “H37Rv” may depend on the
laboratory in which it is maintained and the associated unique
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genetic characteristics. Knowledge of the genome sequences of
individual strains used in each lab might be helpful for explain-
ing conflicting experimental data generated in different labs
(e.g., differences in MICs or growth rates), as well as for dis-
tinguishing relevant SNPs associated with phenotypes in iso-
genic mutants (e.g., for identifying drug targets).
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